HomeELIC • STO
add
Elicera Therapeutics AB
Previous close
kr 6.02
Day range
kr 6.00 - kr 6.20
Year range
kr 1.50 - kr 8.43
Market cap
299.95M SEK
Avg Volume
448.16K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.70M | 172.70% |
Operating expense | 5.59M | -18.18% |
Net income | -2.73M | 51.41% |
Net profit margin | -101.33 | 82.18% |
Earnings per share | — | — |
EBITDA | -2.89M | 50.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.66M | 20.68% |
Total assets | 40.90M | 20.80% |
Total liabilities | 10.88M | 36.47% |
Total equity | 30.02M | — |
Shares outstanding | 48.54M | — |
Price to book | 9.71 | — |
Return on assets | -16.57% | — |
Return on capital | -23.04% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.73M | 51.41% |
Cash from operations | -5.99M | 22.53% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -5.99M | 23.59% |
Free cash flow | -5.07M | 12.05% |
About
Founded
2014
Website
Employees
2
